drugset / Trial / NCT00027677
Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors
Treatment
Summary
RATIONALE: Halofuginone hydrobromide may stop the growth of solid tumors by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of halofuginone hydrobromide in treating patients who have progressive advanced solid tumors.
Timeline
- Start
- 2001-08
- Primary completion
- 2004-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | halofuginone | Small molecule | — | Oral |